Literature DB >> 33470377

LYMPHOPARIETAL INDEX IN ESOPHAGEAL CANCER IS STRONGER THAN TNM STAGING IN LONG-TERM SURVIVAL PROGNOSIS IN A LATIN-AMERICAN COUNTRY.

Manuel Figueroa-Giralt1, Catalina Valenzuela1, Andrés Torrealba1, Attila Csendes1, Italo Braghetto1, Enrique Lanzarini1, Maher Musleh1, Owen Korn1, Hector Valladares1, Solange CortÉs1.   

Abstract

BACKGROUND: The identification of prognostic factors of esophageal cancer has allowed to predict the evolution of patients. AIM: Assess different prognostic factors of long-term survival of esophageal cancer and evaluate a new prognostic factor of long-term survival called lymphoparietal index (N+/T).
METHOD: Prospective study of the Universidad de Chile Clinical Hospital, between January 2004 and December 2013. Included all esophageal cancer surgeries with curative intent and cervical anastomosis. Exclusion criteria included: stage 4 cancers, R1 resections, palliative procedures and emergency surgeries.
RESULTS: Fifty-eight patients were included, 62.1% were men, the average age was 63.3 years. A total of 48.3% were squamous, 88% were advanced cancers, the average lymph node harvest was 17.1. Post-operative surgical morbidity was 75%, with a 17.2% of reoperations and 3.4% of mortality. The average overall survival was 41.3 months, the 3-year survival was 31%. Multivariate analysis of the prognostic factors showed that significant variables were anterior mediastinal ascent (p=0.01, OR: 6.7 [1.43-31.6]), anastomotic fistula (p=0.03, OR: 0.21 [0.05-0.87]), N classification (p=0.02, OR: 3.8 [1.16-12.73]), TNM stage (p=0.04, OR: 2.8 [1.01-9.26]), and lymphoparietal index (p=0.04, RR: 3.9 [1.01-15.17]. The ROC curves of lymphoparietal index, N classification and TNM stage have areas under the curve of 0.71, 0.63 and 0.64 respectively, with significant statistical difference (p=0.01).
CONCLUSION: The independent prognostic factors of long-term survival in esophageal cancer are anterior mediastinal ascent, anastomotic fistula, N classification, TNM stage and lymphoparietal index. In esophageal cancer the new lymphoparietal index is stronger than TNM stage in long-term survival prognosis.

Entities:  

Mesh:

Year:  2021        PMID: 33470377      PMCID: PMC7812684          DOI: 10.1590/0102-672020200003e1547

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  24 in total

1.  Reconstruction after esophagectomy for esophageal cancer: retrosternal or posterior mediastinal route?

Authors:  Mei-Lin Chan; Chih-Cheng Hsieh; Cheng-Wien Wang; Min-Hsiung Huang; Wen-Hu Hsu; Han-Shui Hsu
Journal:  J Chin Med Assoc       Date:  2011-11-04       Impact factor: 2.743

2.  Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.

Authors:  Po-Kuei Hsu; Yu-Chung Wu; Teh-Ying Chou; Chien-Sheng Huang; Wen-Hu Hsu
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

3.  [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].

Authors:  Jean M Butte; Federico Becker; Alvaro Visscher; Enrique Waugh; Manuel Meneses; Ismael Court; Hugo Parada; Hernán DE LA Fuente
Journal:  Rev Med Chil       Date:  2010-03-26       Impact factor: 0.553

4.  [Five years survival rate of 183 patients with epidermoid carcinoma of the esophagus (author's transl)].

Authors:  A Csendes; N Velasco; E Medina
Journal:  Rev Med Chil       Date:  1979-07       Impact factor: 0.553

5.  Novel esophageal reconstruction technique via transmediastinal route from posterior to anterior mediastinum after esophagectomy.

Authors:  Takushi Yasuda; Osamu Shiraishi; Mitsuru Iwama; Tomoki Makino; Hiroaki Kato; Yutaka Kimura
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-13       Impact factor: 5.209

6.  Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival.

Authors:  I Braghetto; A Csendes; G Cardemil; P Burdiles; O Korn; H Valladares
Journal:  Surg Endosc       Date:  2006-09-06       Impact factor: 4.584

7.  Sex Disparity and Copy Number Alterations in Esophageal Squamous Cell Carcinoma.

Authors:  Nina N Sanford; Brandon A Mahal; Trevor J Royce; Luke R G Pike; William L Hwang
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-16       Impact factor: 11.382

8.  Impact of minimally invasive surgery in the treatment of esophageal cancer.

Authors:  M Italo Braghetto; H Gonzalo Cardemil; B Carlos Mandiola; L Gonzalo Masia; S Francesca Gattini
Journal:  Arq Bras Cir Dig       Date:  2014 Nov-Dec

9.  Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.

Authors:  Yaowen Zhang; Jian Li; Lu Wang; Peng Meng; Jiangman Zhao; Peng Han; Jin Xia; Jiangong Xu; Lidong Wang; Fangfang Shen; Anping Zheng; Fuyou Zhou; Ruitai Fan
Journal:  Mol Med Rep       Date:  2019-06-24       Impact factor: 2.952

10.  INTRODUCTION OF THE NEW LYMPHOPARIETAL INDEX FOR GASTRIC CANCER PATIENTS.

Authors:  Manuel Figueroa-Giralt; Attila Csendes; Katya Carrillo; Stefan Danilla; Enrique Lanzarini; Italo Braghetto; Maher Musleh; Solange Cortés
Journal:  Arq Bras Cir Dig       Date:  2019-08-26
View more
  1 in total

1.  NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY TRANSHITAL ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IMPACT OF PATHOLOGICAL COMPLETE RESPONSE.

Authors:  Iuri Pedreira Fillardi Alves; Valdir Tercioti Junior; João de Souza Coelho Neto; José Antonio Possatto Ferrer; José Barreto Campello Carvalheira; Eduardo Baldon Pereira; Luiz Roberto Lopes; Nelson Adami Andreollo
Journal:  Arq Bras Cir Dig       Date:  2022-01-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.